These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 3498203)
1. Identification of factors interacting with a subset of T8+ cells. Pini C; Afferni C; Pellegrini P; Berghella AM; Adorno D; Lanzi G; Prencipe M; Casciani CU Riv Neurol; 1987; 57(1):20-3. PubMed ID: 3498203 [TBL] [Abstract][Full Text] [Related]
2. The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes. Armentrout SA; Sweet PM; Galant SP J Clin Lab Immunol; 1981 May; 5(3):133-6. PubMed ID: 6972451 [TBL] [Abstract][Full Text] [Related]
3. [Determination of a factor inhibiting migration of leukocytes to brain antigens, its concentration in serum and spontaneous leukocyte migration in multiple sclerosis]. Loĭko TP; Ierusalimskiĭ AP; Lozovoĭ VP Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):187-90. PubMed ID: 3518311 [TBL] [Abstract][Full Text] [Related]
4. Suppressor T cells are activated in vivo in patients with multiple sclerosis coinciding with remission from acute attack. Huddlestone JR; Oldstone MB J Immunol; 1982 Sep; 129(3):915-7. PubMed ID: 6213712 [TBL] [Abstract][Full Text] [Related]
5. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients]. Matveeva TV; D'iakonova IN; Shaĭdullina FS Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132 [TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period. Hauser SL; Reinherz EL; Hoban CJ; Schlossman SF; Weiner HL Ann Neurol; 1983 Apr; 13(4):418-25. PubMed ID: 6220668 [TBL] [Abstract][Full Text] [Related]
8. A humoral lymphocyte transformation inhibition factor in multiple sclerosis. Wernicke JF; Sweet PM; van den Noort S; Mayberg HS; Armentrout SA J Clin Lab Immunol; 1983 Dec; 12(4):187-95. PubMed ID: 6198521 [TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma. Butler JL; Ambrus JL; Fauci AS J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336 [TBL] [Abstract][Full Text] [Related]
10. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis. Kastrukoff LF; Paty DW Ann Neurol; 1984 Mar; 15(3):250-6. PubMed ID: 6232891 [TBL] [Abstract][Full Text] [Related]
11. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand. Center DM; Cruikshank WW; Berman JS; Beer DJ J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807 [TBL] [Abstract][Full Text] [Related]
12. Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity. Scott CF; Spitler LE Clin Exp Immunol; 1983 Jul; 53(1):133-9. PubMed ID: 6223730 [TBL] [Abstract][Full Text] [Related]
13. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line. Meltzer MS; Benjamin WR; Farrar JJ J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943 [TBL] [Abstract][Full Text] [Related]
14. A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states. Fox RI; Hueniken M; Fong S; Behar S; Royston I; Singhal SK; Thompson L J Immunol; 1983 Aug; 131(2):762-7. PubMed ID: 6602845 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Hauser SL; Bhan AK; Gilles F; Kemp M; Kerr C; Weiner HL Ann Neurol; 1986 Jun; 19(6):578-87. PubMed ID: 3524414 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M; Iwato K; Kuramoto A J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108 [TBL] [Abstract][Full Text] [Related]
17. Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes. Meuer SC; Hussey RE; Penta AC; Fitzgerald KA; Stadler BM; Schlossman SF; Reinherz EL J Immunol; 1982 Sep; 129(3):1076-9. PubMed ID: 6213706 [TBL] [Abstract][Full Text] [Related]
18. Formation of IgE-binding factors by rat T lymphocytes. VI. Cellular mechanisms for the formation of IgE-potentiating factor and IgE-suppressive factor by antigenic stimulation of antigen-primed spleen cells. Uede T; Ishizaka K J Immunol; 1982 Oct; 129(4):1391-7. PubMed ID: 6980933 [TBL] [Abstract][Full Text] [Related]
19. Low T8 antigen density on lymphocytes in active multiple sclerosis. Reder AT; Antel JP; Oger JJ; McFarland TA; Rosenkoetter M; Arnason BG Ann Neurol; 1984 Aug; 16(2):242-9. PubMed ID: 6236742 [TBL] [Abstract][Full Text] [Related]
20. [Role of immunoregulatory cells and natural killers in the pathogenesis of multiple sclerosis]. Tunkel' OI; Saidov MZ; Cheredeev AN; Koval'chuk LV; Skriabina EG Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):880-5. PubMed ID: 6224384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]